V020-0957 Screening compound: 2-{cyclopropyl[(propan-2-yl)carbamoyl]amino}-N-[1-(3-ethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]acetamide

V020-0957 Screening compound: 2-{cyclopropyl[(propan-2-yl)carbamoyl]amino}-N-[1-(3-ethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]acetamide
V020-0957 Screening compound: 2-{cyclopropyl[(propan-2-yl)carbamoyl]amino}-N-[1-(3-ethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-0957
2-{cyclopropyl[(propan-2-yl)carbamoyl]amino}-N-[1-(3-ethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-0957

Molecular Formula

C26H31N5O3 (C26 H31 N5 O3)

Compound Name

2-{cyclopropyl[(propan-2-yl)carbamoyl]amino}-N-[1-(3-ethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]acetamide

IUPAC name

2-{cyclopropyl[(propan-2-yl)carbamoyl]amino}-N-[1-(3-ethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]acetamide

SMILES

CCOc1cccc(-n2c(NC(CN(C3CC3)C(NC(C)C)=O)=O)nc(-c3ccccc3)c2)c1

InChI

InChI=1S/C26H31N5O3/c1-4-34-22-12-8-11-21(15-22)30-16-23(19-9-6-5-7-10-19)28-25(30)29-24(32)17-31(20-13-14-20)26(33)27-18(2)3/h5-12,15-16,18,20H,4,13-14,17H2,1-3H3,(H,27,33)(H,28,29,32)

InChI Key

CYFMPCHATITCJP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19826606

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

461.56

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.271

Distribution Coefficient, logD

5.271

Water Solubility, LogSw

-4.98

Polar Surface Area

68.481

Acid Dissociation Constant (pKa)

13.41

Base Dissociation Constant (pKb)

2.65

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.60

V020-0957 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V020-0957 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-0957?
Check Price and Availability of V020-0957, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-0957 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-0957
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-0957
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-0957 available by request